Accessed August 7, 2025
Because tirzepatide activates the GIP receptor in addition to the GLP-1 receptor that semaglutide targets, it produces a broader metabolic effect, including stronger appetite suppression, improved insulin sensitivity, and enhanced fat oxidation
The KLOW blend composition is GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg, and KPV 10mg
We take time to understand your health goals, whether youre addressing fatigue, brain fog, or just aiming to feel your best
BPC-157 has been studied across musculoskeletal, gastrointestinal, and neurological models in rats and, in a smaller number of pharmacokinetic studies, in dogs